Evidence map›Paper›PMID 34819353›Full record

ArticleGenes & development2021

A trivalent nucleosome interaction by PHIP/BRWD2 is disrupted in neurodevelopmental disorders and cancer.

Marc A J Morgan, Irina K Popova, Anup Vaidya, Jonathan M Burg, Matthew R Marunde, Emily J Rendleman, Zachary J Dumar, Rachel Watson, Matthew J Meiners, Sarah A Howard and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Tumors and their microenvironments: Learning from pediatric brain pathologies.Biochimica et biophysica acta. Reviews on cancer · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. BRWD3 promotes KDM5 degradation to maintain H3K4 methylation levels.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Marc A J MorganSimpson Querrey Center for Epigenetics, Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Irina K PopovaEpiCypher, Inc., Durham, North Carolina 27709, USA.
Anup VaidyaEpiCypher, Inc., Durham, North Carolina 27709, USA.
Jonathan M BurgEpiCypher, Inc., Durham, North Carolina 27709, USA.
Matthew R MarundeEpiCypher, Inc., Durham, North Carolina 27709, USA.
Emily J RendlemanSimpson Querrey Center for Epigenetics, Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Zachary J DumarSimpson Querrey Center for Epigenetics, Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Rachel WatsonEpiCypher, Inc., Durham, North Carolina 27709, USA.
Matthew J MeinersEpiCypher, Inc., Durham, North Carolina 27709, USA.
Sarah A HowardEpiCypher, Inc., Durham, North Carolina 27709, USA.
Natalia KhalatyanDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Robert M VaughanDepartment of Epigenetics, Van Andel Research Institute, Grand Rapids, Minnesota 49503, USA.
Scott B RothbartDepartment of Epigenetics, Van Andel Research Institute, Grand Rapids, Minnesota 49503, USA.
Michael-C KeoghEpiCypher, Inc., Durham, North Carolina 27709, USA.ORCID 0000-0002-2219-8623
Ali ShilatifardSimpson Querrey Center for Epigenetics, Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
EpiCypher (United States) · USNorthwestern University · USVan Andel Institute · US

Funding

Mutations of Chromatin and its Modifying Machineries in MalignanciesR35CA197569 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Ali Shilatifard · 2015 to 2026
$10.7M
Molecular mechanisms of chromatin and epigenetic regulationR35GM124736 · NIGMS · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2017 to 2021
$2.4M
A novel protein engineering tool for rapid manufacturing of designer nucleosomesR44CA214076 · NCI · EPICYPHER, INC. · PI KEOGH, MICHAEL-CHRISTOPHER · 2018 to 2019
$2.0M
High-throughput methyltransferase assays using recombinant nucleosome substratesR44GM117683 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2018 to 2019
$1.7M
Barcoded nucleosomes for analyzing combinatorial epigenetic regulatorsR44GM116584 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2017 to 2018
$1.6M
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis ComplexK00CA245821 · NCI · MICHIGAN STATE UNIVERSITY · PI VAUGHAN, ROBERT MARK · 2021 to 2024
$374k
DNA methylation regulation through the UHRF1 oncoproteinF99CA245821 · NCI · VAN ANDEL INSTITUTE GRADUATE SCHOOL · PI VAUGHAN, ROBERT MARK · 2019 to 2020
$90k
NCI NIH HHS F99 CA245821NCI NIH HHS K00 CA245821NCI NIH HHS R35 CA197569NCI NIH HHS R44 CA214076NIGMS NIH HHS R35 GM124736NIGMS NIH HHS R44 GM116584NIGMS NIH HHS R44 GM117683
6 · The paper itself

Abstract

Mutations in the

Indexed as

NeoplasmsNeurodevelopmental DisordersBromodomain Containing ProteinsChromatinHistonesHumansMembrane ProteinsNucleosomesProto-Oncogene ProteinsBromodomain Containing ProteinsChromatinHistonesMembrane ProteinsNucleosomesProto-Oncogene ProteinsWDR11 protein, humanchromatinhistoneneurodevelopmental disorderneuroepigenetics

Identifiers

PMID34819353
PMCPMC8653789
OpenAlexW3216028230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.